DK1016867T3 - Fremgangsmåde til immunassay af BNP - Google Patents

Fremgangsmåde til immunassay af BNP

Info

Publication number
DK1016867T3
DK1016867T3 DK98941797T DK98941797T DK1016867T3 DK 1016867 T3 DK1016867 T3 DK 1016867T3 DK 98941797 T DK98941797 T DK 98941797T DK 98941797 T DK98941797 T DK 98941797T DK 1016867 T3 DK1016867 T3 DK 1016867T3
Authority
DK
Denmark
Prior art keywords
bnp
mammalian
immunoassay
gdp
gamma
Prior art date
Application number
DK98941797T
Other languages
English (en)
Inventor
Hiroyuki Shimizu
Kazuaki Endo
Hidehisa Asada
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17152093&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1016867(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK1016867T3 publication Critical patent/DK1016867T3/da

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/58Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK98941797T 1997-09-11 1998-09-10 Fremgangsmåde til immunassay af BNP DK1016867T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP24668497 1997-09-11

Publications (1)

Publication Number Publication Date
DK1016867T3 true DK1016867T3 (da) 2006-05-22

Family

ID=17152093

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98941797T DK1016867T3 (da) 1997-09-11 1998-09-10 Fremgangsmåde til immunassay af BNP

Country Status (13)

Country Link
US (1) US6828107B2 (da)
EP (1) EP1016867B1 (da)
JP (1) JP3516655B2 (da)
KR (1) KR100563358B1 (da)
CN (1) CN1161609C (da)
AT (1) ATE315228T1 (da)
AU (1) AU731858B2 (da)
CA (1) CA2304263C (da)
DE (1) DE69833118T2 (da)
DK (1) DK1016867T3 (da)
ES (1) ES2256952T3 (da)
NO (1) NO325020B1 (da)
WO (1) WO1999013331A1 (da)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
WO2003016910A1 (en) * 2001-08-20 2003-02-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20030199000A1 (en) * 2001-08-20 2003-10-23 Valkirs Gunars E. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US7632647B2 (en) * 2001-04-13 2009-12-15 Biosite Incorporated Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US20040176914A1 (en) * 2001-04-13 2004-09-09 Biosite Incorporated Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
US7608406B2 (en) * 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040209307A1 (en) * 2001-08-20 2004-10-21 Biosite Incorporated Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20040219509A1 (en) * 2001-08-20 2004-11-04 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
JP3691803B2 (ja) * 2002-03-14 2005-09-07 三洋化成工業株式会社 血液中の心不全マーカー定量方法
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
CN102533972B (zh) 2002-05-09 2014-07-02 布赖汉姆妇女医院 作为心血管病的标志和治疗靶的1l1rl-1
FR2843396B1 (fr) * 2002-08-07 2005-04-15 Bio Rad Pasteur Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
US7109023B2 (en) * 2002-11-18 2006-09-19 Princeton Biomeditech Corporation Immunossay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
US7135329B2 (en) * 2002-11-18 2006-11-14 Princeton Biomeditech Corporation Immunoassay device for diagnosing congestive heart failure and predicting mortality in congestive heart failure patients
DK1638443T3 (da) * 2003-06-20 2011-02-07 Mayo Foundation Isoformer af hjerne-natriuretisk peptid
JP2007525213A (ja) * 2004-01-27 2007-09-06 コンピュゲン ユーエスエイ,インク. 新規の脳性ナトリウム利尿ペプチドの変異体及びその利用方法
US20080182299A1 (en) * 2004-01-27 2008-07-31 Compugent Ltd. Novel brain natriuretic peptide variants and methods of use thereof
ES2352845T3 (es) * 2004-03-19 2011-02-23 BIOMEDICA MEDIZINPRODUKTE GMBH & CO KG Métodos de pronóstico para la insuficiencia cardiaca congestiva.
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
US20060051825A1 (en) * 2004-09-09 2006-03-09 Buechler Kenneth F Methods and compositions for measuring canine BNP and uses thereof
US7731965B2 (en) * 2005-02-17 2010-06-08 Abbott Lab Human ring specific BNP antibodies
US7939069B2 (en) 2005-11-09 2011-05-10 Abbott Laboratories Human BNP immunospecific antibodies
JP5364378B2 (ja) 2005-11-09 2013-12-11 アボット・ラボラトリーズ ヒトbnp免疫特異的抗体
CA2650201C (en) 2006-04-24 2020-10-20 James V. Snider Predicting mortality and detecting severe disease
EP3059594A1 (en) * 2006-05-01 2016-08-24 Critical Care Diagnostics, Inc. Prognosis of cardiovascular disease
MX2009001459A (es) 2006-08-08 2009-02-19 Mayo Foundation Polipeptidos diureticos y natriureticos.
US20080064045A1 (en) 2006-09-07 2008-03-13 Huaiqin Wu Biomarker fragments for the detection of human BNP
US20080108147A1 (en) * 2006-11-03 2008-05-08 Tie Wei Reduction of non-specific binding in immunoassays
WO2008095052A2 (en) 2007-01-30 2008-08-07 Loma Vista Medical, Inc., Biological navigation device
AT504942B1 (de) 2007-03-07 2009-08-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
FI20075251A0 (fi) * 2007-04-13 2007-04-13 Hytest Oy Immunomääritys epästabiilien antigeenien määrittämiseksi
US20080280377A1 (en) * 2007-05-08 2008-11-13 Abbott Laboratories Human b-type natriuretic peptide assay having reduced cross-reactivity with other peptide forms
WO2009036448A2 (en) * 2007-09-15 2009-03-19 Mayo Foundation For Medical Education And Research Natriuretic peptide receptor-c agonists
WO2009086126A2 (en) * 2007-12-21 2009-07-09 Mayo Foundation For Medical Education And Research Natriuretic polypeptides
ES2590213T3 (es) 2008-04-18 2016-11-18 Critical Care Diagnostics, Inc. Predicción del riesgo a sufrir episodios cardíacos adversos graves
WO2009149108A1 (en) 2008-06-02 2009-12-10 Loma Vista Medical, Inc. Inflatable medical devices
CN102334031B (zh) * 2008-12-08 2014-10-08 美艾利尔圣地亚哥有限公司 组合的尿钠肽检测
CN101923090A (zh) * 2009-06-10 2010-12-22 中国科学院电子学研究所 固定人体脑钠肽的光学敏感膜的制备方法
EP2593171B1 (en) 2010-07-13 2019-08-28 Loma Vista Medical, Inc. Inflatable medical devices
US8778699B2 (en) 2010-08-04 2014-07-15 Idexx Laboratories, Inc. Detection of degradation products of canine NT-proBNP
US10188436B2 (en) 2010-11-09 2019-01-29 Loma Vista Medical, Inc. Inflatable medical devices
EP2715353B1 (en) 2011-05-31 2016-08-24 IDEXX Laboratories, Inc. DETECTION OF DEGRADATION PRODUCTS OF FELINE NT-proBNP
CN103906761B (zh) 2011-08-30 2016-12-21 梅约医学教育与研究基金会 利钠多肽
US9611305B2 (en) 2012-01-06 2017-04-04 Mayo Foundation For Medical Education And Research Treating cardiovascular or renal diseases
WO2014031764A1 (en) 2012-08-21 2014-02-27 Critical Care Diagnostics, Inc. Multimarker risk stratification
CN112710852B (zh) * 2021-03-26 2021-08-03 上海美迪西生物医药股份有限公司 一种gnp多肽的检测试剂盒及检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2676114B2 (ja) * 1990-04-16 1997-11-12 塩野義製薬株式会社 hBNPを認識するモノクローナル抗体および該抗体を用いるhBNPの免疫測定法
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds

Also Published As

Publication number Publication date
ES2256952T3 (es) 2006-07-16
US20030157596A1 (en) 2003-08-21
WO1999013331A1 (fr) 1999-03-18
DE69833118T2 (de) 2006-08-31
KR100563358B1 (ko) 2006-03-22
CN1278919A (zh) 2001-01-03
NO325020B1 (no) 2008-01-14
CN1161609C (zh) 2004-08-11
AU731858B2 (en) 2001-04-05
EP1016867B1 (en) 2006-01-04
AU9001098A (en) 1999-03-29
NO20001273L (no) 2000-05-10
NO20001273D0 (no) 2000-03-10
US6828107B2 (en) 2004-12-07
CA2304263C (en) 2008-07-29
JP3516655B2 (ja) 2004-04-05
EP1016867A4 (en) 2004-11-17
KR20010023853A (ko) 2001-03-26
CA2304263A1 (en) 1999-03-18
EP1016867A1 (en) 2000-07-05
ATE315228T1 (de) 2006-02-15
DE69833118D1 (de) 2006-03-30

Similar Documents

Publication Publication Date Title
DK1016867T3 (da) Fremgangsmåde til immunassay af BNP
DE69902676T2 (de) Assay unter verwendung von porositätsverminderung zur verhinderung von migration
DK212986A (da) Fremgangsmaade til bestemmelse af et stof i en praeve
ES2151528T3 (es) Composicion de calibrador o control para un ensayo de serologia igm.
ES8506902A1 (es) Un procedimiento para la purificacion de un antigeno.
EP0227440A3 (en) Immunoassay for creatine kinase mb using bound and soluble antibodies
ES2194139T3 (es) Aumento de la sensibilidad en la determinacion inmunoquimica de un analito.
ES2183251T3 (es) Determinacion inmunoquimica de analitos multivalentes.
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
EP0829723A3 (de) Homogene Nachweisverfahren zur Bestimmung von Subpopulationen eines Analyten
EP1072888A3 (en) Immunoassay method and reagent for HIV-1p24 antigen
KR850002385A (ko) PIVKA-Ⅱ의 측정(assay)용 방법 및 시약
DK0709455T3 (da) Monoklonalt antistof med humanglicentin, hybridoma til fremstilling af antistoffet og assaymetode for humanglicentin ved an
DK0492499T3 (da) Fremgangsmåde til bestemmelse af en analyt
DE69310667T2 (de) Immunoassayverfahren unter Anwendung photothermischer Strahlablenkungsspektroskopie
EP1045248A3 (en) Luminescent labeled immunoassay method and analysis element therefor
DE59606685D1 (de) Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
DE69533904D1 (de) Chemische Modifikation von Antikörpern und Antigenen
DE69021921D1 (de) Monoklonale Antikörper gegen den C-Terminus von ANP.
FI860936A (fi) Menetelmä ja reagenssi luteinisoivan hormonin määrittämiseksi sekä tähän tarkoitukseen sopivat monoklonaaliset vasta-aineet
DE69727975D1 (de) 5-hydroxytryptophol (5-htol) derivate, antikörper, immunoassays und detektion von kürzfristigem alkoholkonsum
ATE263784T1 (de) Anti-megakaryozyten monoklonaler antikörper 97a6
CA2110019A1 (en) Immunoassays for determining vitamin b12, and reagents and kits therefor
DK0565903T3 (da) Fremgangsmåde til immunologisk bestemmelse af en eller flere analyter
KR880000794A (ko) 샌드위치식 면역분석용 시약 복합물